Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure

The Food and Drug Administration approved Pfizer's (PFE) hemophilia B gene therapy on Friday, a one-time treatment that will cost $3.5 million in the U.S.…

Related Keywords

,Drug Administration ,Pfizer ,Orchard Therapeutics ,News ,Ggregator ,Reaking News ,Uration ,Media ,